Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

G Protein-Coupled Receptors (GPCRs) Overview

By Jeyashree Sundaram, MBA G protein-coupled receptors (GPCR), G-protein linked receptors, serpentine receptors, or heptahelical receptors are the largest superfamily of membrane proteins in the human genome. Credit: Carl Dupont/Shutterstock.com GPCRs possess

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

By Jeyashree Sundaram, MBA

G protein-coupled receptors (GPCR), G-protein linked receptors, serpentine receptors, or heptahelical receptors are the largest superfamily of membrane proteins in the human genome.

Credit: Carl Dupont/Shutterstock.com

GPCRs possess a heptahelical structure and support normal transmembrane cell signaling processes for growth and cellular development. They are mainly found in eukaryotes but have also been observed in some prokaryotes.

GPCRs are primarily involved in initiating the sensory and regulatory mechanism of cells, acting as receptors for internal actuators and external ligands, respectively.

Various physiological functions, including the development of immune systems and cell metabolism, necessitate the use of GPCRs. For this reason, they also act as drug targets inthe treatment of psychological and mental disorders.

Structure

GPCRs are the largest superfamily of protein receptors found in the human genome. They are protein receptors that possess a seven alpha-helical transmembrane core with a carboxyl-terminus (C-terminus) and an amino-terminus (N-terminus) in the interior and exterior of the membrane, respectively.

The human genome encodes around 800 individual G coupled protein receptors, of which the olfactory receptors constitute a major segment (nearly 460 GPCRs).

Classification

The protein receptors are briefly classified into six families, based on the similarity in their sequential arrangement:

Class A (the rhodopsin family):

The rhodopsin family consists of 701 members (about 80% of the overall species). The structural elements of this family are mostly incorporated within the alpha group. The beta, gamma, and delta forms are found only in few proteins of this family.

Class B (the secretin family):

The secretin family has with 15 members and possesses a large N-terminus extracellular domain, where each domain comprises nearly 160 residues and plays a vital role in specifying ligand binding.

Class C (metabotropic glutamate-like receptor family):

The Metabotropic glutamate-like receptor (mGluRs) family consists of 15 metabotropic receptors that are attached to the cell membrane via their associated G protein. These receptors are a type of excitatory neurotransmitter that are activated through an indirect metabotropic process.

Class D (fungal mating pheromone receptor family):

This class constitutes about 20 distinct, highly diverged protein receptors that are specific for peptide pheromones. Class D is further classified into two important subfamilies-Ste2 and Ste3; as the sequential homology between these two subfamilies varies.

Class E (cyclic-AMP receptor family):

Class E of the GPCR constitutes cyclic adenosine monophosphate (cAMP) receptors from a protozoan amoeba (Dictyostelium discoideum) that is involved in several chemotaxis signaling systems.

Class F (frizzled receptor family):

The frizzled receptors of Drosophila constitute Class F of the GPCR. They are fundamental for mediating hedgehog signaling and Wnt binding.

Visualization and Labeling

Visualization of GPCRs is carried out in order to study the cellular and molecular processes that are involved in sequestration, regulation of translocation, degradation of GPCRs, and recycling. There are various techniques that can be used to visualize GPCRs.

Immune fluorescence

The immune fluorescence (IF) method allows the visualization of GPCRs in living cell membranes, and utilizes either antibodies that are targeted against the extracellular receptor domains or an N-terminal epitope tag.

Other elements, such as C-terminal epitope tags and intracellular receptor units, can also be visualized, however this requires permeabilization and cell fixation. Using this method, receptors that are limited to the membranes and subcellular levels can be seen.

This method is also helpful in the simultaneous detection of both C-terminal and N-terminal epitope tags.

Auto-fluorescent proteins (AFPs)

Fluorescent proteins serve as a potent tool in examination of GPCRs. This is a conventional and a noninvasive imaging method, often involved in the process of supervising the trafficking, gene expression, and intracellular distribution.

Improvements in this method including photo-activation, photo-switching, fluorescence detecting sensors, and timers offer several new approaches in the fluorescence labeling mechanisms that are involved in the study of various cellular functions and parameters, accurate to the level of a single molecule.

Peptide- and protein-tags

Visualization of GPCRs is also performed via selective integration of fluorophores with the protein or peptide tags that are genetically encoded. This method was developed as an alternative to the auto-fluorescent proteins (AFPs) and is utilized in a wide range of in-vivo imaging techniques.

Labeling methods are distinguished into two major types:

1. Enzymatic labeling: an irreversible covalent labeling mechanism that offers high stability and more preferred in detailed examination of a specific protein.

2. Affinity labeling: this technique is based on the non-covalent chelation process.I It is a simple labeling mechanism with high selectivity and is used in several sites within a specified protein.

Fluorescent ligands

Fluorescent ligands have been used extensively to study the interactions between ligands and receptors, wherein antagonists or agonists are usually used as tagging ligands.

Antagonists typically bind to their corresponding GPCR with high affinity and therefore offer an improved noise to signal ratio compared to that of agonists.

Sources:

  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845202/
  • http://www.jbc.org/content/272/23/14817.full.html
  • http://www.mdpi.com/1424-8247/4/4/652/pdf
  • http://diposit.ub.edu/dspace/bitstream/2445/36250/2/1.INTRODUCTION.pdf
  • citeseerx.ist.psu.edu/.../download
  • https://biosignaling.biomedcentral.com/articles/10.1186/1478-811X-7-16

Further Reading

  • All Cell Signaling Content
  • The cAMP signaling pathway
  • Phosphatidylinositol Biphosphate (PIP2) Signal Pathway
  • GPCR Signaling Pathways
  • GPCR Origin and Diversification

Last Updated: Feb 26, 2019

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Could you start by telling us what D-amino acids are and what role they have in a healthy human body?

All living systems are made up of L-amino acids – we will call them left-handed amino acids - and D-amino acids are a mirror image of these. We will call those the right-handed amino acids. As with your right and left hand, one is a non-superimposable mirror image to the other. D-amino acids were originally thought to be unnatural and useless. We now know this is not the case. We are finding that they play important roles in a variety of biological processes. Image Credit: Shutterstock/ Christoph Burgstedt

Source: www.news-medical.net ↗
02How does this p53 targeted therapy differ from traditional cancer treatments?

Traditional cancer treatments have been largely unfocused in that they indiscriminately kill dividing cells, cancer or otherwise, which often leads to significant toxic side effects in patients. Targeted therapies on the other hand, try to inhibit one or more abnormal proteins that are found in proliferating cancer cells resulting in programmed cell death. One or more mutations in the p53 gene are found in at least 50% of all human cancers. These mutations begin a sequence of events that leads to loss of control of cell growth and proliferation. Due to its central importance in many human cancers, drugs that restore function to mutated p53 proteins have been described as one of the three holy grails of cancer research. Targeting specific abnormal proteins found only in cancer cells could be expected to be associated with less toxicity in normal healthy cells.

Source: www.news-medical.net ↗
03Your early research focused on predicting molecular properties such as solubility using machine learning. What did that teach you about data-driven property prediction?

Data-driven models, such as Quantitative Structure Activity Relationships (QSAR), are incredibly attractive because they offer rapid methods for predicting molecular properties, including those that are difficult to access through fundamental chemical and physical theory. For new molecules, in related regions of chemical space to the training data, they can often be very accurate. The challenge is that they typically do not generalize across large diverse chemical and biological spaces. Therefore real care is needed when applying them to novel chemistry or biology. Some attempts to build more widely applicable QSAR models have been made in recent years, but most models in use today are still built for specific chemistries and properties owing to the scale and complexity of chemical space. When I started this work, especially for solubility predictions, the datasets were modest by today’s standards, often hundreds to a few thousand molecules. One of the first things that teaches you is to explore the data carefully, assess its quality and quantity, and only then move forward with modeling. The aim is to capture genuine relationships between numerical molecular descriptions and important target endpoints, but those relationships may be only locally generalizable. I also think the phrase “simple descriptors” is interesting. Some are simple, such as atom counts or bond counts, but others rely on detailed parameterization, group contributions, and graph-theoretical techniques. We still see these descriptors used today, sometimes alongside embeddings from graph neural networks or language models. The main lesson for me is that there is no single workflow. Each dataset, model, and end-use case needs careful thought.

Source: www.news-medical.net ↗
04Your research has focused extensively on axon biology and small non-coding RNAs (sncRNAs). Can you explain why the study of sncRNAs in axons is significant and how it impacts our understanding of neuronal function? What impact does this have on drug discovery?

As an analogy, when the axon is scaled up to be the arm in a human body, you can think of the axon length in relation to the neuron's cell body as the equivalent distance from Nottingham to Paris. This significant length poses a logistical challenge for the neuron. For proteins to be expressed at the axon terminal, which is distant from the cell body, there's a requirement for translation regulation. In other words, there is a need for descentralized gene expression. Here, small non-coding RNAs play a pivotal role. Our work on microRNAs has shown their importance in spatial-temporal control of gene expression. This research aligns with the current interest in RNA biology and offers potential avenues for drug discovery, especially given the advances in RNA technologies post-covid.

Source: www.news-medical.net ↗
05What are BCAAs?

Food-derived proteins are broken down during digestion releasing amino acids which are then used by the body to create proteins required by bodily organs, tissues, and cells. The body can code for 20 different types of amino acids. However, some amino acids are considered to be essential whereby they cannot be synthesized in large enough quantities by the body. Therefore, they must be consumed as part of a balanced diet. Non-essential amino acids are produced by the body. There are nine types of essential amino acids: phenylalanine, histidine, threonine, isoleucine, leucine, tryptophan, lysine, valine, and methionine. Of the nine essential amino acids, leucine, valine, and isoleucine are referred to as branched-chain amino acids. Generally, all three BCAAs act as a substrate to produce protein and energy. Leucine plays an additional role as an intercellular signaling regulator for the mechanisms of protein production. Typically, BCAAs are found in foods rich in proteins such as eggs, fish, red meat, dairy and chicken as well as soy proteins, nuts, and lentils. Research has found that as the production of protein is continuous, there is a need to replace lost protein. This need for continued protein intake has increased the popularity of BCAA supplements. For example, the inclusion of BCAA supplements into the diets of bodybuilders, athletes, and gym-goers has increased due to their proposed muscle-building benefits and ability to enhance performance.

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →